BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23076651)

  • 21. Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane.
    Ishihara M; Hu J; Zhang X; Choi Y; Wong A; Cano-Ruiz C; Zhao R; Tan P; Tso JL; Wu L
    J Vis Exp; 2020 Feb; (156):. PubMed ID: 32091005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma.
    Riesenberg R; Weiler C; Spring O; Eder M; Buchner A; Popp T; Castro M; Kammerer R; Takikawa O; Hatz RA; Stief CG; Hofstetter A; Zimmermann W
    Clin Cancer Res; 2007 Dec; 13(23):6993-7002. PubMed ID: 18056175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The chick embryo chorioallantoic membrane in the study of tumor angiogenesis.
    Ribatti D
    Rom J Morphol Embryol; 2008; 49(2):131-5. PubMed ID: 18516317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects.
    Gao W; Jin K; Lan H; Han N; Cao F; Teng L
    Hepatogastroenterology; 2012; 59(120):2543-7. PubMed ID: 22534543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type.
    Cai Q; Christie A; Rajaram S; Zhou Q; Araj E; Chintalapati S; Cadeddu J; Margulis V; Pedrosa I; Rakheja D; McKay RM; Brugarolas J; Kapur P
    EBioMedicine; 2020 Jan; 51():102526. PubMed ID: 31859241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells.
    Tang SW; Chang WH; Su YC; Chen YC; Lai YH; Wu PT; Hsu CI; Lin WC; Lai MK; Lin JY
    Cancer Lett; 2009 Jan; 273(1):35-43. PubMed ID: 18809243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-chloride Intracellular Channel Protein 1 (CLIC1) Antibodies Induce Tumour Necrosis and Angiogenesis Inhibition on
    Radu-Cosnita AD; Nesiu A; Berzava PL; Cerbu S; Cosma A; Comsa S; Sarb S; Ferician AM; Ferician OC; Cimpean AM
    Anticancer Res; 2022 Mar; 42(3):1313-1325. PubMed ID: 35220222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
    Rodins K; Cheale M; Coleman N; Fox SB
    Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The In Ovo Chick Chorioallantoic Membrane (CAM) Assay as an Efficient Xenograft Model of Hepatocellular Carcinoma.
    Li M; Pathak RR; Lopez-Rivera E; Friedman SL; Aguirre-Ghiso JA; Sikora AG
    J Vis Exp; 2015 Oct; (104):. PubMed ID: 26484588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methods for Analyzing Tumor Angiogenesis in the Chick Chorioallantoic Membrane Model.
    Ames JJ; Henderson T; Liaw L; Brooks PC
    Methods Mol Biol; 2016; 1406():255-69. PubMed ID: 26820962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The entire miR-200 seed family is strongly deregulated in clear cell renal cell cancer compared to the proximal tubular epithelial cells of the kidney.
    Duns G; van den Berg A; van Dijk MC; van Duivenbode I; Giezen C; Kluiver J; van Goor H; Hofstra RM; van den Berg E; Kok K
    Genes Chromosomes Cancer; 2013 Feb; 52(2):165-73. PubMed ID: 23074016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular endothelial growth factor trap blocks tumor growth, metastasis formation, and vascular leakage in an orthotopic murine renal cell cancer model.
    Verheul HM; Hammers H; van Erp K; Wei Y; Sanni T; Salumbides B; Qian DZ; Yancopoulos GD; Pili R
    Clin Cancer Res; 2007 Jul; 13(14):4201-8. PubMed ID: 17634549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NF-KappaB expression correlates with apoptosis and angiogenesis in clear cell renal cell carcinoma tissues.
    Meteoglu I; Erdogdu IH; Meydan N; Erkus M; Barutca S
    J Exp Clin Cancer Res; 2008 Oct; 27(1):53. PubMed ID: 18928570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The chick embryo chorioallantoic membrane as a model to study tumor metastasis.
    Cimpean AM; Ribatti D; Raica M
    Angiogenesis; 2008; 11(4):311-9. PubMed ID: 18780151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas.
    Hemmerlein B; Galuschka L; Putzer N; Zischkau S; Heuser M
    Histopathology; 2004 Dec; 45(6):603-11. PubMed ID: 15569051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of gastrin releasing Peptide receptor in renal cell carcinomas: a potential function for the regulation of neoangiogenesis and microvascular perfusion.
    Heuser M; Schlott T; Schally AV; Kahler E; Schliephake R; Laabs SO; Hemmerlein B
    J Urol; 2005 Jun; 173(6):2154-9. PubMed ID: 15879878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PPARγ is functionally expressed in clear cell renal cell carcinoma.
    Collet N; Théoleyre S; Rageul J; Mottier S; Jouan F; Rioux-Leclercq N; Fergelot P; Patard JJ; Masson D; Denis MG
    Int J Oncol; 2011 Mar; 38(3):851-7. PubMed ID: 21206970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene signatures of progression and metastasis in renal cell cancer.
    Jones J; Otu H; Spentzos D; Kolia S; Inan M; Beecken WD; Fellbaum C; Gu X; Joseph M; Pantuck AJ; Jonas D; Libermann TA
    Clin Cancer Res; 2005 Aug; 11(16):5730-9. PubMed ID: 16115910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noninvasive Contrast-Free 3D Evaluation of Tumor Angiogenesis with Ultrasensitive Ultrasound Microvessel Imaging.
    Huang C; Lowerison MR; Lucien F; Gong P; Wang D; Song P; Chen S
    Sci Rep; 2019 Mar; 9(1):4907. PubMed ID: 30894634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of the actin regulator HSPC300 results in clear cell renal cell carcinoma protection in Von Hippel-Lindau patients.
    Cascón A; Escobar B; Montero-Conde C; Rodríguez-Antona C; Ruiz-Llorente S; Osorio A; Mercadillo F; Letón R; Campos JM; García-Sagredo JM; Benítez J; Malumbres M; Robledo M
    Hum Mutat; 2007 Jun; 28(6):613-21. PubMed ID: 17311301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.